G - Physics
01
N
G01N 33/50 (2006.01) G01N 33/574 (2006.01)
Patent
CA 2581041
The invention relates to methods of diagnosis and prognosis of cancer, the methods comprising determining the level of one or more gene products. In addition, the invention relates to modulators of the gene products for use in treatment of cancer. The genes include E1A-induced genes and Numb.
L'invention concerne des méthodes diagnostiques et pronostiques du cancer, qui consistent à déterminer le niveau d'un ou de plusieurs produits géniques. L'invention concerne en outre des modulateurs des produits géniques à utiliser dans le traitement du cancer. Lesdits produits géniques comprennent des gènes induits par la protéine E1A et la protéine Numb.
Bianchi Fabrizio
Bonapace Ian Marc
Confalonieri Stefano
Di Fiore Pier Paolo
Nicassio Francesco
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Ifom Fondazione Istituto Firc Di Oncologia Molecolare
LandOfFree
Cancer markers does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cancer markers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cancer markers will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1559206